Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg

Lancet. 1995 Aug 19;346(8973):459-61. doi: 10.1016/s0140-6736(95)91320-3.

Abstract

Deep-vein thrombosis is common after plaster-cast immobilisation for traumatic injury. We did a randomised prospective study of the effect of low-molecular-weight heparin on the incidence of deep-vein thrombosis in patients with minor injuries treated with plaster-cast immobilisation of the leg. A control group (n = 163) received no prophylaxis, the prophylaxis group received low-molecular-weight heparin once daily (n = 176). The incidence of deep-vein thrombosis in the prophylaxis group was 0% (one tailed p < 0.006) vs 4.3% in the control group. No severe side-effects of low-molecular-weight heparin were observed. Thromboprophylaxis with low-molecular-weight heparin once daily is effective in reducing the risk of deep-vein thrombosis in outpatients with plaster-cast immobilisation of the leg.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Casts, Surgical*
  • Female
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Immobilization / adverse effects*
  • Incidence
  • Injections, Subcutaneous
  • Leg Injuries / therapy*
  • Male
  • Middle Aged
  • Outpatients
  • Premedication
  • Prospective Studies
  • Thrombophlebitis / etiology
  • Thrombophlebitis / prevention & control*

Substances

  • Heparin, Low-Molecular-Weight